Cancer;Breast Cancer;Women

Study: New Biomarker Tool Helps Select Targeted Therapies to Treat Metastatic Breast Cancers

[ad_1] Newswise — Two antibody drug conjugates (ADCs), trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG), were approved by the FDA…